U.S. prosecutors are bearing down on generic pharmaceutical companies in a sweeping criminal investigation into suspected price collusion, a fresh challenge for an industry that's already reeling from public outrage over the spiraling costs of some medicines.
U.S. Charges in Generic-Drug Probe to Be Filed Soon
Comment
Show comments
Hide Comments
